RZLT Insider Trading
Insider Ownership Percentage: 18.39%
Insider Buying (Last 12 Months): $455,325.41
Insider Selling (Last 12 Months): $0.00
Rezolute Share Price & Price History
Current Price: $2.47
Price Change: +0.30 (1.20%)
As of 04/11/2025 05:00 PM ET
Rezolute Insider Trading History
Rezolute Institutional Trading History
Data available starting January 2016
Rezolute, Inc., a clinical stage biopharmaceutical company, develops therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder. It is also developing RZ402, an oral plasma kallikrein inhibitor, which is in clinical trial for the chronic treatment of diabetic macular edema. The company was formerly known as AntriaBio, Inc. and changed its name to Rezolute, Inc. in December 2017. Rezolute, Inc. was incorporated in 2010 and is headquartered in Redwood City, California.
Read More on Rezolute
Volume
316,270 shs
Average Volume
504,609 shs
Market Capitalization
$149.52 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.97
Who are the company insiders with the largest holdings of Rezolute?